News Archives

This is the archive of news updates from the Fuji Pharma website.
Click on each news item to view the full details.

2026.02.10
Release(リリース): Notice of Application for Marketing Approval and Launch of Emergency Contraceptive Pill "LESOERU®72"
2026.02.05
Financial Results(決算資料): Supplemental Materials of 1Q/FY2026 Consolidated Financial Results
2026.02.05
Financial Results(決算資料): Financial Results of 1Q/FY2026
2026.02.05
Financial Results(決算資料): Notice Regarding Revision of Earnings Forecast
2026.02.05
Financial Results(決算資料): Notice Regarding Loss on Valuation of Securities for the First Quarter of the Fiscal Year ending September 2026
2026.02.03
Release(リリース): Richter and Fuji strengthen strategic collaboration
2026.01.30
Release(リリース): Notice of Licensing and Settlement Regarding Aflibercept 2mg BS (Biosimilar)
2026.01.27
Other(その他): FY2025 Company Research and Analysis Report (Published by FISCO Ltd.)
2026.01.20
Release(リリース): Marketing Approval for new specification of Ustekinumab Biosimilar ― USTEKINUMAB BS 90㎎ Syringe for S.C. Injection「F」―
2025.11.27
Other(その他): Notice of the 61th Ordinary General Meeting of Shareholders